Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $15.42 Analyst target: $22.93 Upside: 48.70%
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The company is headquartered in New Haven, Connecticut.
See the full interactive analysis & chart →Informational only — not investment advice.